Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Kyoto Prefectural University of Medicine

Japan · Asia-Pacific · Silver

#368World rank of 1,038
58.5ICI scoreout of 100
#32National rank, of 52 in Japan
#102Regional rank, of 343 in Asia-Pacific
359.5Verified industry works, 2021 to 2025
156Company groups worked with (65 on two or more works)

Kyoto Prefectural University of Medicine is ranked #368 of 1,038, with Silver standing. Its strongest pillar is co-creation (85): 359.5 verified industry works against about 243 expected for its mix of fields. It is held back most by breadth (30): partners concentrated in a few research fields; and by scale (43): a network of 65 company groups on two or more joint works.

Research Collaboration Index 2026: #1143 of 1,195 · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
85

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 359.5 verified works against about 243 expected for its fields (1.48 times the expected rate).

Durability20% of the score
71

How much of its industry work sits in sustained partnerships with the same company group. 19 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
43

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 65 company groups on two or more joint works; 19 sustained partnerships.

Breadth20% of the score
30

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (58.5) is the weighted average of the four percentiles. Rank 368 of 1,038 overall; 32 of 52 in Japan; 102 of 343 in Asia-Pacific. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

7.5%of its 4,781 research works in 2021 to 2025 were co-authored with a verified company
1.48Industry co-authorship rate: 1.48 times what its mix of research fields would predict (359.5 verified works; about 243 expected)
19sustained partnerships: the same company group on five or more joint works in three or more of the five years

In Japan

32 of 52 ranked universities in Japan

  1. #30 Nihon University world #332, score 60.9
  2. #31 Tokai University world #333, score 60.8
  3. #32 Kyoto Prefectural University of Medicine world #368, score 58.5
  4. #33 Gifu University world #384, score 57.5
  5. #34 Yokohama National University world #412, score 56.3

All ranked universities →   Asia-Pacific: 102 of 343 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Sector positions

#326 of 638Pharmaceuticals and Therapeutics77 verified works in the sector
Pharmaceuticals and Therapeutics
77#326 of 638
Biotechnology and Advanced Therapies
13.5under 20 works
Medical Technology and Digital Health
12under 20 works
Advanced Materials and Nanotechnology
3under 20 works
Agriculture and Food Technology
2under 20 works
Climate, Environment and Sustainability
1under 20 works
Not in any of the 21 sectors
250.5counted in the overall index

109 of its 359.5 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Kyoto Prefectural University of Medicine co-authored verified work with 156 company groups, consortium papers aside: 65 of them on two or more works, and 19 as sustained partners.

The largest 12 of its 156 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
Daiichi SankyoJapanMedicine31.55 of 5
PanasonicJapanEngineering245 of 5
Eli LillyUnited StatesMedicine15.54 of 5
SanofiFranceMedicine155 of 5
AbbVieUnited StatesMedicine135 of 5
Leo PharmaDenmarkMedicine133 of 5
RegeneronUnited StatesMedicine124 of 5
SCREENJapanEngineering11.55 of 5
Agilent TechnologiesUnited StatesEngineering103 of 5
PfizerUnited StatesMedicine94 of 5
TakaraJapanBiochemistry, Genetics and Molecular Biology83 of 5
Takara BIO Inc.JapanBiochemistry, Genetics and Molecular Biology83 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

722021
642022
762023
77.52024
702025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Evidence checked

492 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 236 of 728 candidate links were set aside.

Why links were set aside
  • 80 part of a university or public institute's own unit
  • 68 company name not written in the author's affiliation
  • 42 a place or common word that failed its stricter rule
  • 23 ordinary-word name without a company suffix
  • 7 excluded after hand audit: Matched from university rheumatology centres (King's College London)
  • 6 refresh_university_not_on_work
  • 10 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Silver standing badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where Kyoto Prefectural University of Medicine's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Kyoto Prefectural University of Medicine ranks #1143 of 1,195. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.